Could Medical Imaging Account for 10% of Childhood Blood Cancers?

In this article
Summary: Data from 3.7 million children showed that radiation exposure above 30 mGy was associated with hematological cancer risk 1.76 times higher. Approximately 10.1%of hematological cancers in this age group may be attributable to high-dose medical imaging. (1 head CT ≈ 13.7 mGy)
Imaging decisions for children and adolescents depend on the benefit–risk balance . Published on 17 September 2025 in NEJM , a new study involving 3.7 million people found an association between cumulative radiation reaching bone marrow and hematological (blood and bone marrow) cancer risk that was small but statistically significant . It reinforces using high-dose tests such as CT only when truly necessary and with the lowest reasonably achievable dose (ALARA).
📏 What Does Radiation Dose Mean?
Radiationis invisible energy carried as waves or particles. In medical imaging, it usually comes from X-rays and similar sources and is measured in mGy (milligray) . Dose represents energy transferred to tissues.
⚡ Imaging Using Radiation
- X-Ray: For example, chest X-ray (~0.1 mGy)
- Computed Tomography (CT): For example, head CT (~13.7 mGy), abdominal CT (~15–20 mGy)
- Nuclear Medicine: PET, scintigraphy (injected radioactive material)
🛡️ Imaging Without Radiation
- Ultrasound (US): Uses sound waves without radiation.
- Magnetic Resonance Imaging (MRI): Uses magnetic fields and radio waves without radiation.
🔢 Example Dose Comparisons
- 1 Chest X-Ray: ~0.1 mGy
- 1 Head CT: ~13.7 mGy
- 1 Abdominal CT: ~15–20 mGy
- 30 mGy Exposure: In the study, associated with a 76% increase in cancer risk.
Note: Although individual test doses are low, repeated CT scans increase cumulative exposure.
Study Design
- Cohort: From the US and Canada, 3,724,623 children born in 1996–2016.
- Follow-Up: Total: 35,715,325 person-years (mean 10.1 years/person), ending at cancer/benign tumor, death, insurance termination, age 21 or 31 December 2017.
- Exposure: Medical imaging dose to active bone marrow (mGy).
- Analysis: Continuous-time hazards models with a 6-month lag .
📊 Diagnoses
Total: 2961 hematological cancers:
• Lymphoid: 79.3% • Myeloid/Acute Leukemia: 15.5% • Histiocytic/Dendritic: 4.4%
💡 Dose Equivalent
One head CT ≈ 13.7 mGy (reference comparison).
📈 Excess Cases
≥30 mGy (mean 57 mGy) exposure was associated with, by age 21, an additional 25.6/10,000 cases.
Attributable Risk %
Approximately 10.1%of cohort cases (confidence interval: 5.8–14.2%) may be attributable to medical imaging radiation.
📋 Relative Risk (RR) by Dose Range
| Cumulative Dose (mGy) | RR (No Exposure = 1.00) | 95% CI |
|---|---|---|
| 1 – <5 mGy | 1.41 | 1.11 – 1.78 |
| 15 – <20 mGy | 1.82 | 1.33 – 2.43 |
| 50 – <100 mGy | 3.59 | 2.22 – 5.44 |
| Note: ERR per 100 mGy = 2.54 (95% CI, 1.70–3.51; p<0.001). 30 mGy vs 0 mGy RR = 1.76 (95% CI, 1.51–2.05). |
||

🎯 Clinical Implications
- Careful Indication: High-dose tests such as CT require justification .
- Dose Optimization: Pediatric protocols, size-based adjustment and avoiding repeat tests.
- Alternatives: Where appropriate, US/MRI may be preferred.
- Documentation and Communication: Record exposure and communicate risks transparently with parents.
🛠️ 5 Practical Steps
- Initial Assessment: Is the clinical question clear? Will imaging change management?
- Choose the Modality: Where possible, US/MRI; if CT is needed, use a pediatric dose protocol.
- Avoid Repetition: Retrieve/share prior examinations; dose registry.
- ALARA Training: Periodic education for pediatric and pediatric emergency teams.
- Inform Parents: Use concrete comparisons such as "One head CT ≈ 13.7 mGy" to explain risk.
❓ Brief Summary for Physicians and Parents
In Brief: As cumulative radiation to children's bone marrow increases, hematological cancer risk measurably rises. The risk is small but significant, making a clear indication and the lowest dose essential.
📚 Source
Smith-Bindman R, Alber SA, Kwan ML, Pequeno P, Bolch WE, Bowles EJA, Greenlee RT, et al.
Medical Imaging and Pediatric and Adolescent Hematologic Cancer Risk. New England Journal of Medicine. Published: 17 September 2025. DOI: 10.1056/NEJMoa2502098
Was this article helpful?
Your feedback helps us improve our content.





Reader comments
Share your comment
Your name and comment are published only after administrator approval. Your email address is never shown to visitors.
Be the first to comment.